Floatz logo

8 assets in B-Cell Prolymphocytic Leukemia

Therapeutic assets addressing B-Cell Prolymphocytic Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Fludarabine
B-Cell Prolymphocytic Leukemia
Sumithira VasuP2BB (65)
Etoposide
B-Cell Prolymphocytic Leukemia
City of Hope Medical CenterP2BB (64)
Cyclophosphamide
B-Cell Prolymphocytic Leukemia
Sumithira VasuP2B (63)
Ibrutinib
B-Cell Prolymphocytic Leukemia
City of Hope Medical CenterP1CC (47)
Autologous Cd19Car-Cd28-Cd3Zeta-Egfrt-Expressing Tn/Mem-Enriched T-Lymphocytes
B-Cell Prolymphocytic Leukemia
City of Hope Medical CenterP1CC (43)
Bendamustine
B-Cell Prolymphocytic Leukemia
City of Hope Medical CenterP1CC (43)
cd22 car-transduced t cells
B-Cell Prolymphocytic Leukemia
Sumithira VasuP1CC (43)
Pevonedistat
B-Cell Prolymphocytic Leukemia
City of Hope Medical CenterP1CC (43)